openPR Logo
Press release

Dual Energy X-Ray Absorptiometry (DEXA) Market Forecast: US$ 387.5 Million by 2033 at 4.9% CAGR | North America Tops with 40% Share | Leading Players: GE HealthCare, OSTEOSYS, Xuzhou Pinyuan

12-05-2025 08:03 AM CET | Health & Medicine

Press release from: DataM intelligence 4 Market Research LLP

Dual Energy X-Ray Absorptiometry (DEXA) Market

Dual Energy X-Ray Absorptiometry (DEXA) Market

Global Dual Energy X-Ray Absorptiometry (DEXA) Market reached US$ 252.9 million in 2024 and is projected to reach US$ 387.5 million by 2033, growing at a CAGR of 4.9 percent during the forecast period 2025-2033. The market is expanding steadily as DEXA technology remains the gold standard for evaluating bone mineral density (BMD) and assessing body composition with high precision. By using two X-ray beams at different energy levels, DEXA enables accurate differentiation between bone, muscle and fat tissues, making it essential for diagnosing osteoporosis, monitoring bone health and supporting clinical decision-making in metabolic and musculoskeletal disorders.

Demand is rising globally due to the growing prevalence of osteoporosis and the increasing need for early detection of bone-related conditions. According to the Bone Health & Osteoporosis Foundation, an estimated 10 million people in the U.S. have osteoporosis, while 44 million have low bone density, highlighting the substantial screening requirement. The aging population, increased focus on preventive healthcare and the expanding use of DEXA in sports medicine, obesity management and geriatric care are further strengthening market growth. As healthcare providers emphasize accurate, non-invasive diagnostic tools, DEXA systems continue to gain traction worldwide.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/dual-energy-x-ray-absorptiometry-market?sai-v

The DEXA Market advances bone and body composition analysis with highly accurate, low-dose imaging systems used for osteoporosis screening and clinical diagnostics.

Key Developments
✅ May 2025: Hospitals in the United States upgraded to AI-assisted DEXA scanners to improve bone density measurement accuracy and reduce scan interpretation time for osteoporosis screening.

✅ June 2025: Healthcare providers in Germany adopted portable DEXA systems to support mobile diagnostics for elderly populations and community-based bone health programs.

✅ July 2025: Diagnostic centers in Japan integrated high-speed DEXA imaging platforms with cloud connectivity for remote radiology review and enhanced fracture-risk assessment.

✅ August 2025: Clinics across Australia implemented low-dose DEXA machines to expand sports medicine and metabolic health diagnostics, especially for athletes and obesity management programs.

✅ September 2025: Hospitals in Canada incorporated next-gen multi-site bone densitometry tools capable of simultaneously scanning spine, hip, and forearm regions for improved clinical workflow efficiency.

✅ October 2025: Medical institutions in India adopted advanced DEXA systems with body composition analysis to support rising demand in preventive healthcare, nutrition assessment, and chronic disease monitoring.

Mergers & Acquisitions
✅ June 2025: A major U.S.-based medical imaging company acquired a European DEXA technology firm to strengthen its portfolio of bone densitometry and metabolic health imaging solutions.

✅ August 2025: A leading Japanese healthcare device manufacturer formed a strategic alliance with an Australian diagnostics provider to jointly develop portable DEXA scanners for regional deployment.

✅ October 2025: A prominent European imaging systems developer partnered with an Indian healthcare technology company to co-develop cloud-enabled DEXA platforms for emerging markets.

Key Players
GE HealthCare | Hologic, Inc. | OSTEOSYS Corp. | DMS Group | Swissray International, Inc. | Xuzhou Pinyuan Electronic Technology Co., Ltd. | FUJIFILM Holdings Corporation | Scintica Instrumentation, Inc. | IDETEC MEDICAL IMAGING | Trivitron Healthcare | Others

Key Highlights
• GE HealthCare - Holds an estimated 21.4% share, driven by its strong global brand, advanced DEXA imaging portfolio, and widespread adoption across hospitals and diagnostic centers.

• Hologic, Inc. - Accounts for around 19.8% share, supported by its leadership in women's health diagnostics, innovative bone density systems, and strong clinical validation.

• OSTEOSYS Corp. - Maintains approximately 11.6% share, fueled by its cost-effective DEXA systems, expanding presence in Asia, and rising demand in mid-sized healthcare settings.

• DMS Group - Represents nearly 7.9% share, known for its compact, high-precision bone densitometry devices and strong foothold in the European diagnostics market.

• Swissray International, Inc. - Holds about 5.4% share, driven by its advanced imaging solutions, growing installation base, and focus on improving skeletal health diagnostics.

• Xuzhou Pinyuan Electronic Technology Co., Ltd. - Accounts for around 6.7% share, supported by competitively priced DEXA equipment and increasing adoption in emerging markets.

• FUJIFILM Holdings Corporation - Maintains roughly 8.2% share, backed by its robust imaging technologies, global distribution strength, and integration of advanced digital radiography capabilities.

• Scintica Instrumentation, Inc. - Represents approximately 3.5% share, recognized for its research-focused bone density measurement systems used across academic and clinical R&D.

• IDETEC MEDICAL IMAGING - Holds an estimated 2.9% share, supported by specialized imaging systems and growing acceptance in niche clinical applications.

• Trivitron Healthcare - Accounts for around 4.1% share, driven by its expanding product portfolio, strong distribution networks in Asia and the Middle East, and focus on accessible diagnostic solutions.

• Others - Collectively contribute roughly 8.5% share, comprising regional players and specialized imaging manufacturers offering budget-friendly and customized DEXA systems.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=dual-energy-x-ray-absorptiometry-market?sai-v

Market Drivers

- Rising prevalence of osteoporosis, osteopenia, and age-related bone disorders driving demand for accurate bone density assessment.

- Increasing adoption of DEXA systems for body composition analysis in sports medicine, wellness centers, and clinical settings.

- Growing geriatric population worldwide, leading to higher screening needs for fracture risk and bone health monitoring.

- Advancements in imaging technology enabling faster scans, improved accuracy, and lower radiation exposure.

- Expansion of preventive healthcare programs focused on early detection of bone health issues.

- Rising incidence of obesity and metabolic disorders boosting use of DEXA for fat and lean mass measurement.

- Increasing investments in hospital imaging infrastructure and diagnostic capabilities across emerging economies.

Industry Developments

- Launch of next-generation DEXA scanners with enhanced imaging resolution, automated bone mapping, and advanced AI-based analytics.

- Growing integration of DEXA technology into fitness, sports performance, and personalized health programs.

- Development of portable and mobile DEXA units enabling community-based bone screening and remote diagnostics.

- Strategic collaborations between imaging device manufacturers and healthcare institutions to expand diagnostic coverage.

- Increased adoption of cloud-enabled reporting and digital data management tools for DEXA-based assessments.

Regional Insights

North America - 40%, driven by "high osteoporosis screening rates, advanced imaging infrastructure, and strong adoption of body composition analysis in sports and clinical settings."

Europe - 32%, supported by "growing focus on preventive bone health diagnostics, strong healthcare reimbursement systems, and expanding geriatric population."

Asia Pacific - 24%, fueled by "rising awareness of osteoporosis, increasing healthcare investments, and rapid expansion of diagnostic imaging facilities."

Latin America - 3%, driven by "growing need for bone density testing and improved accessibility to advanced imaging systems."

Middle East & Africa - 1%, supported by "increasing healthcare modernization, rising burden of metabolic diseases, and growing demand for bone health assessments."

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/dual-energy-x-ray-absorptiometry-market?sai-v

Key Segments

➥ By Type
Peripheral DEXA systems are compact, cost-effective devices commonly used for screening bone density in specific regions such as the wrist, heel, or forearm. They offer quick assessments, making them suitable for primary care settings, community health programs, and routine osteoporosis screening. Central DEXA systems, considered the gold standard, provide highly accurate measurements of the spine and hip, enabling comprehensive diagnosis, fracture risk assessment, and treatment monitoring for osteoporosis and related conditions.

➥ By Application
Bone densitometry remains the primary application, supporting early detection of osteoporosis, monitoring bone loss, and evaluating treatment effectiveness. Pediatric assessments utilize DEXA technology to evaluate bone health in children, helping diagnose growth-related abnormalities, nutritional deficiencies, and metabolic bone disorders. Others include body composition analysis, fat and lean mass evaluation, and research-based measurements used in sports science and metabolic studies.

➥ By End-User
Hospitals use DEXA systems for clinical diagnostics, fracture risk assessment, and integrated care pathways involving endocrinology, geriatrics, and orthopedics. Diagnostic centers rely on DEXA equipment for specialized imaging services, high patient throughput, and reliable bone health evaluations. Research institutes utilize DEXA for clinical studies, epidemiological research, pediatric growth studies, and body composition science. Others include sports medicine facilities, rehabilitation centers, mobile screening units, and private clinics adopting DEXA for preventive health and wellness applications.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dual Energy X-Ray Absorptiometry (DEXA) Market Forecast: US$ 387.5 Million by 2033 at 4.9% CAGR | North America Tops with 40% Share | Leading Players: GE HealthCare, OSTEOSYS, Xuzhou Pinyuan here

News-ID: 4301874 • Views:

More Releases from DataM intelligence 4 Market Research LLP

Rheology Modifiers Market Set for Steady Growth to USD 13.55 Billion by 2034, Led by North America's 39% Global Market Share | DataM Intelligence
Rheology Modifiers Market Set for Steady Growth to USD 13.55 Billion by 2034, Le …
The Global Rheology Modifiers Market is valued at approximately USD 9.32 billion in 2025 and is projected to reach about USD 13.55 billion by 2034, growing at a CAGR of around 4.25% during the forecast period from 2025 to 2034.​ This steady growth is driven by rising demand in paints and coatings, personal care, cosmetics, and increased shale gas exploration along with crude oil production. Advancements in eco-friendly and bio-based rheology
Global Niemann-Pick Disease Type C (NPC) market is expected to reach US$ 923.57 million by 2033 - growing at a CAGR of 28.9%, NPC1 segment holds 92% market revenue
Global Niemann-Pick Disease Type C (NPC) market is expected to reach US$ 923.57 …
The Global Niemann-Pick Disease Type C (NPC) market reached US$ 9.00 million in 2024 and is expected to reach US$ 923.57 million by 2033, growing at a CAGR of 28.9% during the forecast period of 2025-2033. The Niemann-Pick Disease Type C market is growing due to rising global awareness, improved genetic screening, and increased diagnosis rates. Advancements in targeted therapies, strong R&D investment, and expanded clinical trials are accelerating innovation. Supportive
Ventricular Assist Devices Market Set for Strong Growth at 10% CAGR by 2031, Led by North America's 58% Global Market Share | DataM Intelligence
Ventricular Assist Devices Market Set for Strong Growth at 10% CAGR by 2031, Led …
The Global Ventricular Assist Devices (VADs) Market is projected to grow at a strong CAGR of 10% during the forecast period 2024-2031. Market growth is fueled by the rising prevalence of heart failure, increasing adoption of mechanical circulatory support devices, and advancements in miniaturized, durable VAD technologies. Furthermore, a growing aging population, improved survival rates post-cardiac surgeries, and expanding use of VADs as both bridge-to-transplant and destination therapy are contributing to
AC Power Source Market to Grow at 4.3% CAGR Through 2030 | North America Dominates with 38% | Major Players: Keysight Technologies, B&K Precision, REGATRON
AC Power Source Market to Grow at 4.3% CAGR Through 2030 | North America Dominat …
The Global AC Power Source Market is projected to grow at a CAGR of 4.3% during 2023-2030, driven by increasing demand for reliable and configurable power testing solutions across industrial, commercial and research environments. AC power sources are capable of generating a wide range of sine waveforms-including surges, traps and dimmed phase waves, to accurately simulate real-world electrical conditions. Key technologies in this space include AC voltage stabilizers and frequency

All 5 Releases


More Releases for DEXA

DEXA Devices Research:CAGR of 4.2% during the forecast period
QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report "DEXA Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031". Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2025-2031), this report provides a comprehensive analysis of the global Wire Drawing Dies market, including market size, share, demand, industry development status, and forecasts for the next few years. The
DEXA Devices Market Comprehensive Report 2024: Size, Growth Prospects, and Regio …
The global DEXA Devices market was valued at US$ 330.41 million in 2023 and it is expected to reach US$ 402.50 million by the end of 2030, growing at a CAGR of 4.18% during 2024-2030. A 2024 latest Report by QYResearch offers on -"DEXA Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030" provides an extensive examination of DEXA Devices market attributes, size assessments, and growth
Dual-energy X-ray Absorptiometry (DEXA) Market Size, Share, Growth, Forecast and …
"Dual-energy X-ray Absorptiometry (DEXA) Market 2023," The objectives outlined in the report are multifaceted and aimed at offering a comprehensive understanding of the Dual-energy X-ray Absorptiometry (DEXA) market dynamics. These objectives encompass a meticulous analysis and forecast of the market's dimensions, encompassing both its value and volume aspects. Additionally, the report seeks to discern and delineate the market shares held by major segments within the Dual-energy X-ray Absorptiometry (DEXA) industry, providing
Global DEXA Bone Sonometers Market - Opportunities & Forecasts, 2020-2029
Dhirtek Business Research and Consulting recently released its most comprehensive research report to date on the global dexa bone sonometers market. Through extensive research, analysts have provided an extensive look into the market's drivers and restraints, and identified the key milestones and trends that will shape its future. Primary and secondary research methods were used to create this in-depth report. Through the analysis of the research, Dhirtek was able
DEXA Bone Densitometers Market: Competitive Dynamics & Global Outlook 2024
Market Research Report Store offers a latest published report on DEXA Bone Densitometers Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. According to this study, over the next five years the DEXA Bone Densitometers market will register a 4.2% CAGR in terms of revenue, the global market size will reach US$ 305.5 million by 2024, from US$ 259 million in
Global DEXA Bone Densitometers Market Expected to Witness a Sustainable Growth o …
New report published by Market Research Report Store (MRRS) which offers insights on the global DEXA Bone Densitometers market. Bone densitometry, also called dual-energy x-ray absorptiometry or DEXA, uses a very small dose of ionizing radiation to produce pictures of the inside of the body (usually the lower spine and hips) to measure bone loss. It is commonly used to diagnose osteoporosis and to assess an individual’s risk for developing fractures.